Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Valneva, Maintains $25 Price Target By Benzinga Newsdesk February 17, 7:16 AM HC Wainwright & Co. analyst Edward White reiterates Valneva (NASDAQ:VALN) with a Buy and maintains $25 price target. VALN
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Sage Therapeutics, Maintains $70 Price Target By Benzinga Newsdesk February 17, 7:14 AM Needham analyst Ami Fadia reiterates Sage Therapeutics (NASDAQ:SAGE) with a Buy and maintains $70 price target. SAGE
Read More 1 minute read Analyst Ratings News Price Target Reiteration Telsey Advisory Group Reiterates Outperform on Bath & Body Works, Maintains $52 Price Target By Benzinga Newsdesk February 17, 7:10 AM Telsey Advisory Group analyst Dana Telsey reiterates Bath & Body Works (NYSE:BBWI) with a Outperform and maintains $52 price target. BBWI
Read More 1 minute read Analyst Ratings News Price Target Reiteration Telsey Advisory Group Reiterates Market Perform on Ross Stores, Maintains $120 Price Target By Benzinga Newsdesk February 17, 7:06 AM Telsey Advisory Group analyst Dana Telsey reiterates Ross Stores (NASDAQ:ROST) with a Market Perform and maintains $120 price target. ROST
Read More 1 minute read Analyst Ratings News Price Target Reiteration Barrington Research Reiterates Outperform on Avantax, Raises Price Target to $35 By Benzinga Newsdesk February 17, 6:40 AM Barrington Research analyst Alexander Paris reiterates Avantax (NASDAQ:AVTA) with a Outperform and raises the price target from $30 to $35. AVTA
Read More 1 minute read Analyst Ratings News Price Target Reiteration Jefferies Reiterates Buy on Star Bulk Carriers, Maintains $26 Price Target By Benzinga Newsdesk February 17, 6:02 AM Jefferies analyst Omar Nokta reiterates Star Bulk Carriers (NASDAQ:SBLK) with a Buy and maintains $26 price target. SBLK
Read More 1 minute read Analyst Ratings News Price Target Reiteration Stephens & Co. Reiterates Overweight on Chuy’s Holdings, Maintains $33 Price Target By Benzinga Newsdesk February 17, 5:58 AM Stephens & Co. analyst Joshua Long reiterates Chuy's Holdings (NASDAQ:CHUY) with a Overweight and maintains $33 price target. CHUY
Read More 1 minute read Analyst Ratings News Price Target Reiteration Canaccord Genuity Reiterates Buy on Repay Hldgs, Maintains $20 Price Target By Benzinga Newsdesk February 17, 5:54 AM Canaccord Genuity analyst Joseph Vafi reiterates Repay Hldgs (NASDAQ:RPAY) with a Buy and maintains $20 price target. RPAY
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Inozyme Pharma, Maintains $23 Price Target By Benzinga Newsdesk February 17, 5:48 AM Needham analyst Joseph Stringer reiterates Inozyme Pharma (NASDAQ:INZY) with a Buy and maintains $23 price target. INZY
Read More 1 minute read Analyst Color Analyst Ratings Biotech Earnings Beats General Guidance Health Care Large Cap Movers News Reiteration Trading Ideas Analyst Views West Pharmaceutical’s Q4 Earnings Impressive Despite Headwinds By Vandana Singh February 16, 1:48 PM West Pharmaceutical Services Inc (NYSE:WST) reported Q4 2022 net sales of $708.7 million, down 3%, and organic net sales growth… WST